RedHill Biopharma Announces Q3/22 Results and Operational Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
RedHill Biopharma (RDHL) Misses Q2 EPS by 4c
November 29, 2022 8:03 AM ESTRedHill Biopharma (NASDAQ: RDHL) reported Q2 EPS of ($0.06), $0.04 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $17.6 million versus the consensus estimate of $23.19 million.
For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.
... More